InBios awarded $12.67 million DOD contract to Increase domestic production of rapid point of care COVID-19 tests
On Oct. 30, 2020 InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Oct. 30, 2020 InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Oct. 29, 2020, the National Institutes of Health (NIH) announed that it will begin requiring most of…
On Oct. 29, 2020, the Centers for Disease Control and Prevention (CDC) opened its new South America regional…
On Oct. 29, 2020, the University of Oxford announced a new pilot scheme to assess the use of…
On Oct. 29, 2020, OncoSec Medical announced that the FDA had approved the Investigational New Drug (IND) application…
On Oct. 29, 2020, PerkinElmer announced that the FDA had issued Emergency Use Authorization (EUA) to allow sample…
On Oct. 29, 2020, Emulate announced that it had entered into a Cooperative Research and Development Agreement (CRADA)…
On Oct. 28, 2020, Novartis and Molecular Partners announced an option and license agreement to develop, manufacture and…
On Oct. 28, 2020, CVS Health announced plans to expand COVID-19 testing services currently offered at select CVS…
On Oct. 28, 2020, researchers at the NIH announced that they had discovered a biological pathway that the…
On Oct. 28, 2020, Eli Lilly announced the New England Journal of Medicine had published data from the…
On Oct. 28, 2020, Abiomed announced the first two patients were treated with the Impella ECP expandable percutaneous…
On Oct. 28, 2020, researchers at the University of Nebraska Medical Center (UNMC) reported the results of a…
On Oct. 28, 2020, Regeneron announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the…
On Oct. 27, 2020, CHF Solutions announced that it had shipped Aquadexル product to medical facilities in Tennessee…
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
On Oct. 27, 2020, Nektar Therapeutics announced that it has received FDA clearance for an Investigational New Drug…
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
On Oct. 26, 2020, Bayer announced the acquisition of Asklepios BioPharmaceutical, a North Carolina-headquartered biopharmaceutical company specialized in…
On Oct. 26, 2020, ContraFect announced that it had initiated an expanded access program to provide exebacase for…
On Oct. 26, 2020, Taconic Biosciences announced immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2…
On Oct. 26, 2020, Membrion announced a breakthrough in the fight against the COVID-19 virus: a molecular coating…
On Oct. 23, 2020, Entos Pharmaceuticals announced it was receiving advisory services and funding of up to $5…
On Oct. 23, 2020, AstraZeneca announced that the clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, had…
On Oct. 23, 2020, Johnson & Johnson announced that it was preparing to resume recruitment in the pivotal…
On Oct. 22, 2020, Roche and Atea Pharmaceuticals announced they had joined forces in the fight against COVID-19…
On Oct. 22, 2020, the City of Vacaville announced the start of the next generation of development of…
On Oct. 15, 2020 research teams from two divisions of the Allen Institute, the Allen Institute for Cell…
On Oct. 13, 2020, NeoGenomics announced plans to open a state-of-the-art research laboratory in China in association with…
On Oct. 8, 2020, UNICEF, World Health Organization (WHO), the World Bank Group and the Population Division of…